Efficacy and Safety of mitapivat in a subset of hereditary hemolytic anemias: a systematic review, meta-analysis, and GRADE assessment of randomized controlled trials
Annals of Hematology · 20.11.2026
DOI: 10.1007/s00277-026-07364-8 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annals of Hematology, online erschienen am 20.11.2026. Verfasst von Humayou Ahmed und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ahmed, H., Zulfiqar, D., Abbasi, M., Mehmood, K., Hamid, M., Ahsun, H., Hassan, M., Khan, M. S., Fida, S., Humayun, M. R., Shahzad, Z., & Al-Dhaheri, M. (2026). Efficacy and Safety of mitapivat in a subset of hereditary hemolytic anemias: a systematic review, meta-analysis, and GRADE assessment of randomized controlled trials. Annals of Hematology. https://doi.org/10.1007/s00277-026-07364-8
Vancouver
Ahmed H, Zulfiqar D, Abbasi M, Mehmood K, Hamid M, Ahsun H, et al. Efficacy and Safety of mitapivat in a subset of hereditary hemolytic anemias: a systematic review, meta-analysis, and GRADE assessment of randomized controlled trials. Annals of Hematology. 2026. doi:10.1007/s00277-026-07364-8
BibTeX
@article{Ahmed2026,
author = {Ahmed, Humayou and Zulfiqar, Daniyal and Abbasi, Maryam and Mehmood, Kainat and Hamid, Maheen and Ahsun, Hafsa and Hassan, Mohammad and Khan, Muhammad Saad and Fida, Sameen and Humayun, Muhammad Rayyan and Shahzad, Zain and Al-Dhaheri, Manal},
title = {Efficacy and Safety of mitapivat in a subset of hereditary hemolytic anemias: a systematic review, meta-analysis, and GRADE assessment of randomized controlled trials},
journal = {Annals of Hematology},
year = {2026},
doi = {10.1007/s00277-026-07364-8}
}
EUVIMED